Science ❯ Genetics
Animal Cloning CRISPR Applications Gene Editing CRISPR-Cas Systems Genome Editing Gene Regulation
RBC raised its target to $50 after a weak quarter, with Vertex projecting more than $100 million in 2025 sales.
